Baring Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
6,017
-179
-3% -$41.7K 0.84% 33
2026
Q1
$1.51M Buy
6,196
+436
+8% +$102K 0.93% 30
2025
Q4
$1.19M Buy
5,760
+61
+1% +$12.1K 0.73% 36
2025
Q3
$1.06M Sell
5,699
-6
-0.1% -$1.03K 0.72% 37
2025
Q2
$871K Sell
5,705
-79
-1% -$12.1K 0.65% 38
2025
Q1
$959K Buy
5,784
+163
+3% +$25.5K 0.81% 35
2024
Q4
$813K Buy
+5,621
New +$871K 0.72% 38

Other funds holding JNJ

Baring Financial's JNJ Position: Q2 2026 in Review

Baring Financial reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, selling an estimated $41.7K and leaving 6,017 shares worth $1.53M. The position accounts for 0.84% of the portfolio, ranked #33.

Baring Financial first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Baring Financial held 6,017 shares of Johnson & Johnson worth $1.53M as of Q2 2026.
  • Baring Financial sold 179 Johnson & Johnson shares in Q2 2026, an estimated $41.7K.
  • Johnson & Johnson made up 0.84% of Baring Financial's portfolio in Q2 2026, its #33 holding.
  • Baring Financial first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Baring Financial's 13F filing for Q2 2026, filed 8 Jul 2026.